Scientific Advisory Board
Dr Nizar Tannir
MD Anderson Cancer Center, Houston, US
Professor, Deputy Department Chair, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, US.
Dr Bernard Escudier
Gustave Roussy, Villejuif, Paris, France
MD. Bernard Escudier was chairman of the Gentiourinary tumor board at Gustave Roussy, Villejuif, 2010-2015 and has led multiple phase I to phase III trials as principal investigator. He is interested in renal cell carcinoma, immunotherapy and development of new therapeutic strategies. He was leading the generation of the ESMO guidelines for kidney cancer in 2012, 2014 and 2016.
Dr Petri Bono
Helsinki University Hospital, Helsinki, Finland
MD, PhD. Chief Medical Officer, Helsinki University Hospital, Helsinki, Finland. Petri Bono is specialized in targeted treatment of breast and renal cancer and is a member of ESMO and ASCO. Former appointment at Massachusetts Institute of Technology (MIT), US, and fellow at the Helsinki University Hospital.